K. Veres

425 total citations
11 papers, 333 citations indexed

About

K. Veres is a scholar working on Rheumatology, Immunology and Epidemiology. According to data from OpenAlex, K. Veres has authored 11 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Immunology and 3 papers in Epidemiology. Recurrent topics in K. Veres's work include Systemic Lupus Erythematosus Research (6 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). K. Veres is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). K. Veres collaborates with scholars based in Hungary, Norway and Israel. K. Veres's co-authors include Pál Soltész, G. Szegedi, Gabriella Lakos, Péter Szodoray, Henrietta Dér, Zoltán Szekanecz, Sándor Sipka, Edit Szomják, Y Shoenfeld and Emese Kiss and has published in prestigious journals such as Lara D. Veeken, Scandinavian Journal of Immunology and Lupus.

In The Last Decade

K. Veres

10 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Veres Hungary 7 214 170 64 53 52 11 333
Maria Rita Gigante Italy 10 188 0.9× 103 0.6× 77 1.2× 53 1.0× 23 0.4× 24 400
Henrietta Dér Hungary 9 234 1.1× 228 1.3× 42 0.7× 74 1.4× 35 0.7× 12 466
Haitao Yu China 8 232 1.1× 200 1.2× 22 0.3× 31 0.6× 44 0.8× 13 378
Alessandra Zanola Italy 9 174 0.8× 101 0.6× 64 1.0× 42 0.8× 36 0.7× 11 365
DD Gladman Canada 12 290 1.4× 192 1.1× 39 0.6× 27 0.5× 21 0.4× 19 341
Shunhua Guo United States 12 138 0.6× 179 1.1× 31 0.5× 32 0.6× 17 0.3× 22 371
T Y Lian Singapore 7 396 1.9× 223 1.3× 37 0.6× 45 0.8× 39 0.8× 13 459
С. И. Глухова Russia 8 205 1.0× 106 0.6× 54 0.8× 23 0.4× 11 0.2× 149 316
Iwona Brzosko Poland 8 146 0.7× 125 0.7× 30 0.5× 28 0.5× 12 0.2× 28 276
Johann O. Schröder Germany 8 124 0.6× 115 0.7× 49 0.8× 37 0.7× 14 0.3× 14 321

Countries citing papers authored by K. Veres

Since Specialization
Citations

This map shows the geographic impact of K. Veres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Veres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Veres more than expected).

Fields of papers citing papers by K. Veres

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Veres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Veres. The network helps show where K. Veres may publish in the future.

Co-authorship network of co-authors of K. Veres

This figure shows the co-authorship network connecting the top 25 collaborators of K. Veres. A scholar is included among the top collaborators of K. Veres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Veres. K. Veres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Szodoray, Péter, K. Veres, Edit Szomják, et al.. (2011). Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome. Lupus. 20(7). 730–735. 31 indexed citations
3.
Szomják, Edit, Henrietta Dér, György Kerekes, et al.. (2010). Immunological Parameters, Including CXCL8 (IL-8) Characterize Cerebro- and Cardiovascular Events in Patients with Peripheral Artery Diseases. Scandinavian Journal of Immunology. 71(4). 283–291. 6 indexed citations
4.
Veres, K., Péter Szodoray, Zoltán Szekanecz, et al.. (2010). Clinical and immunoserological characteristics of the transition from primary to overlap antiphospholipid syndrome. Lupus. 19(13). 1520–1526. 7 indexed citations
5.
Soltész, Pál, Henrietta Dér, K. Veres, et al.. (2008). Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction. Lara D. Veeken. 47(11). 1628–1634. 54 indexed citations
7.
Szodoray, Péter, Orsolya Tímár, K. Veres, et al.. (2006). Th1/Th2 Imbalance, Measured by Circulating and Intracytoplasmic Inflammatory Cytokines – Immunological Alterations in Acute Coronary Syndrome and Stable Coronary Artery Disease. Scandinavian Journal of Immunology. 64(3). 336–344. 73 indexed citations
8.
Veres, K., Gabriella Lakos, Zoltán Szekanecz, et al.. (2004). Antiphospholipid antibodies in acute coronary syndrome. Lupus. 13(6). 423–427. 62 indexed citations
9.
Soltész, Pál, K. Veres, Gabriella Lakos, et al.. (2003). Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients. Lupus. 12(4). 302–307. 50 indexed citations
10.
Veres, K., et al.. (1999). [Sweet syndrome following therapeutic use of granulocyte colony stimulating factor].. PubMed. 140(19). 1059–61. 3 indexed citations
11.
Soltész, Pál, Zoltán Szekanecz, Judit Végh, et al.. (1999). [Catastrophic antiphospholipid antibody syndrome in a cancer patient].. PubMed. 140(52). 2917–20. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026